Endpoints News 2026-02-05 #ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Endpoints News 2026-02-05 Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex
Endpoints News 2026-02-05 Telehealth provider Hims goes after Novo's weight loss pill with compounded version
Endpoints News 2026-02-04 AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira
Endpoints News 2026-02-04 Rare pediatric PRV program reauthorized until 2029 via government funding law
Endpoints News 2026-02-04 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News 2026-02-03 'Turning around the Titanic': How the incoming PBM reforms will transform CMS